Providing the latest care for primary ocular tumors, the Ophthalmic Oncology Center at Duke Eye Center implements an extensive approach to the diagnosis and treatment of various eye cancers.
Miguel Materin, MD
Director, Duke Ophthalmic Oncology
Led by Director Miguel Materin, MD, the center collaborates with the world-renowned Duke Cancer Institute in order to address ophthalmic issues related to systemic cancers and their treatments. The center also works closely with the Duke Center for Ocular Immunology, which uses innovative research to create new possibilities for treatment.
With an accomplished team of top specialists in neurosurgery, pathology, radiation, medical, pediatric, and neuro-oncology, we have considerable experience in diagnosing and treating patients with tumors and conditions like retinoblastoma, uveal melanoma, ocular lymphoma, choroidal hemangiomas, ocular metastases, retinal astrocytic tumors, and ocular tumors related to phacomatoses.
Our dedicated staff helps patients via reduced wait times and for advanced treatment of certain conditions, the center can enroll patients in multi-center clinical trials.
Dr. Materin also supervises the Duke Ocular Oncology and Pathology Fellowship, a one-year program in which fellows experience comprehensive training in medical and surgical care using the latest approaches.
Duke is proud to have one of the few multidisciplinary patient care and research centers for ophthalmic oncology on the East Coast, making it the major referral center for North Carolina and the surrounding region.
The Duke Ophthalmic Oncology Center hopes to continue its efforts to meet the increased demand for specialty treatment of ocular tumors and eye-related effects of systemic cancers.
To refer a patient, please contact Jessica Hill, Ophthalmic Oncology Center Program Coordinator by email email@example.com.